Related Experiment Video
Updated: Jun 25, 2026
10:54
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method
Abebaw Fekadu1, Sarah Wooderson, Catherine Donaldson
1King's College London, Institute of Psychiatry, Section of Neurobiology of Mood Disorders, Department of Psychological Medicine and Psychiatry, London, UK.
The Journal of Clinical Psychiatry
|February 5, 2009
Summary
A new points-based model effectively stages treatment-resistant depression by assessing illness severity, treatment history, and episode duration. This approach offers a more nuanced understanding of treatment resistance compared to existing methods.
Area of Science:
- Psychiatry and Mental Health
- Clinical Psychology
- Pharmacology
Background:
- Treatment resistance is a prevalent challenge in managing depression, yet current staging models lack the granularity to capture its complexity.
- Existing methods for staging treatment-resistant depression (TRD) are often inadequate, failing to account for the multifaceted nature of treatment failure.
Purpose of the Study:
- To develop a novel staging model for treatment-resistant depression (TRD) that incorporates key factors contributing to treatment failure.
- To create a more comprehensive and clinically useful system for categorizing the severity of treatment resistance in depression.
Main Methods:
- Conducted a systematic literature review to identify factors consistently linked to treatment resistance in depression.
- Analyzed data from patients discharged from a specialist inpatient unit to validate the proposed staging model.
- Developed a points-based system integrating illness severity, antidepressant treatment history, and duration of the depressive episode.
Main Results:
- A points-based staging model was devised, incorporating illness severity (subsyndromal to psychotic depression), number of antidepressant treatments, and episode duration.
- The model yields scores ranging from 3 (minimal resistance) to 15 (severe resistance), allowing for categorization into mild, moderate, or severe resistance.
- Analysis of inpatient data supported the predictive validity of the model's components and the overall staging system.
Conclusions:
- The proposed points-based staging model demonstrates reasonable face and predictive validity for treatment-resistant depression.
- This novel model offers potentially greater utility in staging treatment resistance compared to existing, less complex methods.
- The model provides a more refined framework for understanding and managing complex cases of treatment-resistant depression.
